Raymond James Downgrades GoodRx Holdings Inc. (GDRX) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
GoodRx Holdings Inc. (GDRX) PT Lowered to $12 at Goldman Sachs
May 10, 2022 7:00 AM EDTGoldman Sachs analyst Eric Sheridan lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $12.00 (from $30.00) while maintaining a Buy rating.
The analyst commented, "In its Q1 22 earnings report, GoodRx presented a solid quarterly report but framed the forward business trajectory as impacted by a "grocer" partner that had... More
